How big is the rapid medical diagnostic kits market?

The global rapid medical diagnostic kits market size was estimated at USD 21.63 billion in 2022 and is expected to reach USD 23.45 billion in 2023.

What is the rapid medical diagnostic kits market growth?

The global rapid medical diagnostic kits market is expected to grow at a compound annual growth rate of 9.03% from 2023 to 2030 to reach USD 42.94 billion by 2030.

Which segment accounted for the largest rapid diagnostic kits market share?

The blood glucose testing segment held the largest revenue share of 13.46%% in 2022 owing to high usage of these tests and availability of number of rapid blood glucose tests

Who are the key players in the rapid medical diagnostic kits market?

Some key players operating in the rapid medical diagnostic kits market include ACON Laboratories, Inc.; Abbott Laboratories; Artron Laboratories Inc.; Alfa Scientific Designs, Inc.; Becton, Dickinson and Company; BTNX, Inc.; bioMérieux SA; Cardinal Health; Bio-Rad Laboratories, Inc.; Danaher Corporation; Creative Diagnostics; Meridian Bioscience, Inc.

What are the factors driving the rapid medical diagnostic kits market?

Key factors that are driving the rapid medical diagnostic kits market growth include the rise in the prevalence of chronic diseases, a growing number of government initiatives, and growing awareness about rapid diagnostic test kits for fast & easy diagnosis.